Development of MF-59 adjuvant using chitosan derivatives to influenza vaccine
Background & Objective: The influenza virus causes hundreds of deaths in the world. Despite the availability of some authorized vaccines for all age groups and its approved beneficial effects, the influenza is still a major problem for public health. Materials & Methods: In this study, the adjuvant...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Fasa University of Medical Sciences
2020-06-01
|
| Serie: | Journal of Advanced Biomedical Sciences |
| Soggetti: | |
| Accesso online: | http://jabs.fums.ac.ir/article-1-2163-en.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|